Ryrie,
Yes, you are right about the DVN revenue but Bloomers revenue is more than a third of DVN's yet Nomad is only paying one twelfth of the DVN market cap to buy Bloomer. Also in the Nomad general meeting notice for the purchase of Bloomer, they quoted Devine's Enterprise value/EBIT as 9.3 whereas they are paying only 2.6 EV/EBIT for Bloomer. It is hard to imagine how the Nomad Board has got it for this price and no wonder all of the directors grabbed the new shares at 5c. I am a top 20 shareholder but I did not get a chance to pick up any of those new shares.
GPASAS
- Forums
- ASX - By Stock
- NOD
- Loading up
Loading up, page-11
Featured News
Add NOD (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Will Souter, CFO
Will Souter
CFO
Previous Video
Next Video
SPONSORED BY The Market Online